# A Prospective Randomized Double-Blind Trial Comparing 3 Doses of Intravenous Ketorolac for Pain Management

> **NCT02078492** · PHASE4 · COMPLETED · sponsor: **Antonios Likourezos** · enrollment: 240 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** 10 mg of Ketorolac
- **DRUG:** 15 mg of Ketorolac
- **DRUG:** 30 mg of Ketorolac

## Key facts

- **NCT ID:** NCT02078492
- **Lead sponsor:** Antonios Likourezos
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2017-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02078492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02078492, "A Prospective Randomized Double-Blind Trial Comparing 3 Doses of Intravenous Ketorolac for Pain Management". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT02078492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*